[Originally Posted at Forbes]
Insys Therapeutics, the Arizona-based pharmaceutical company that recently became the biggest financial supporter of the campaign against marijuana legalization in that state, makes an oral spray that delivers the opioid painkiller fentanyl and plans to market another one that contains dronabinol, a synthetic version of THC. Insys says it gave $500,000 to the main group opposing Arizona’s legalization initiative because the measure “fails to protect the safety of Arizona’s citizens, and particularly its children.” But one needn’t be terribly cynical to surmise that Insys also worries about the impact that legalization might have on its bottom line, since marijuana could compete with its products. Read the entire article at Forbes.
Funny that a company that is developing marijuana based pharmaceuticals is against legalization. This just goes to show how beneficial marijuana in treating specific ailments. It is completely logical as to why they are against it, as they are capitalizing on the current prohibited status of the substance, but I’d rather see humans advance medically than watch pharmaceutical corporations make billions off of sick people. Although this study does not show a direct link that marijuana reduces pharmceutical deaths, I would say it is highly correlated.
Categories: Health & Wellness